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Reversal of Sodium Arsenite Inhibition of Rat Liver
Microsomal Ca2+ Pumping ATPase by Vitamin C
Odutayo O. Odunuga,1,2 Gbolahan W. Okunade,1 and Olufunso O. Olorunsogo1
Received October 5, 1998
Sodium arsenite (NaAsO2), at 10% of its median lethal dose, was administered to rats with
and without vitamin C pretreatment. Liver microsomal fraction was isolated and the
activity of Ca2+-ATPase was assayed. Sodium arsenite was found to inhibit the activity of
the liver microsomal Ca2+-ATPase to 50% to that of control rats. The specific activity
of the enzyme in rats administered sodium arsenite with vitamin C pretreatment was not
significantly different from that of control rats.
KEY WORDS: Sodium arsenite; inhibition; microsomes; Ca2+-ATPase; reversal;
vitamin C.

INTRODUCTION
Sodium arsenite (NaAsO2) is used widely as a component of insecticides, herbicides,
fungicides, algicides and for killing vegetation. The chemical is highly toxic and has
a high degree of retention in tissues. It has been found that arsenite markedly
decreases total hepatic cytochrome P450 content and dependent monooxygenase
activities [1]. Rumos et al. (1995) [2] have shown that sodium arsenite decreases
glutathione (GSH) levels and increased lipid peroxidation in liver, kidney and heart,
[3] have also shown that arsenite mimics okadaic acid, a potent tumor promoter and
selective inhibitor of phosphatase. Brown and Kitchen (1996) [4] suggested that
sodium arsenite, like phorbol esters, might be a promoter rather than an initiator of
carcinogenesis.
Adenuga et al. (1972) [5] observed that depression of ER Ca2+-ATPase was a
manifestation of the toxicological effect of tumor promoters. Lowry et al. (1981) [6]
have also observed that decreased microsomal calcium pumping is one of the earliest
signs of chemical hepatotoxicity using haloalkanes. Studies on thapsigargin have
shown that it induces Ca2+ mobilization by ER Ca2+ pump inhibition [7]. It has long
been recognized that gap junctional intercellular communication is a function of
cytoplasmic calcium concentration [8]. The endoplasmic reticulum is a major
organelle in the fine regulation of intracellular calcium ion concentration. Therefore,
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the endo (sarco) plasmic reticulum Ca2+-ATPase may play a vital role in the mechanism of action of tumor promoters.
Vitamin C is known generally as a detoxifying agent. Antimutagenic effect of
ascorbic acid has been investigated against mutagenic agents such as dimethylnitrosomine, benzo(a)pyrene, benzidine and aflatoxin B1 [9]. The anticancer effect
of vitamin C is a consequence of the removal of free radicals from the cells.
We report here the effect of sodium arsenite alone and in combination with
vitamin C on the liver microsomal Ca2+ pump.
METHODS
Chemicals
Sodium arsenite and vitamin C were obtained from Sigma Chemical Company,
U.S.A. and BDH Chemicals Ltd., England, respectively. Adenosine triphosphate
(ATP) was also obtained from Sigma Chemical Company. All other chemicals and
reagents were of analytical grade.
ANIMALS
Male Wistar rats were obtained from the Department of Biochemistry, University of Ibadan, Nigeria. The rats were kept in well-ventilated cages and allowed food
and water freely throughout the period of the experiments. The weight of the rats
just before sacrificing were between 130 and 150 g. The control animals (Group A)
were fed normal rat pellets before and during the experiments. Group B rats were
given a mega dose of vitamin C daily for seven (7) days before administration of
sodium arsenite. Animals in Group C received sodium arsenite alone. The sodium
arsenite dose given in each case was 2.4 mg/kg body weight, which is a tenth part
of the LD50 for rats. All drugs were administered by oral intubation. Twenty four
(24) hours after sodium arsenite administration, the rats were starved overnight and
sacrificed by cervical dislocation. Livers were quickly removed, washed in ice-cold
0.2 M sucrose/20 mM Tris, pH 7.2 buffer and weighed.
PREPARATION OF MICROSOMAL FRACTION
10% (w/v) liver homogenates were prepared using the homogenizing buffer,
0.25 M sucrose/20 mM Tris, pH 7.2, by five strokes in a Poter-Elverjem homogenizer. The homogenates were centrifuged at 12,000 g for 20 minutes in a Hermle 2323K centrifuge at 4°C. The microsomal vesicles were sedimented at 105,000g for
1 hr at 4°C in a Beckman L5-50B ultracentrifuge. The microsomal pellets were resuspended in 130 mM KCl/120 mM Tris, pH 7.2 and stored frozen.
PROTEIN DETERMINATION
Protein content was determined by the method of Lowry et al. (1951) [10] using
bovine serum albumin as standard.

Sodium Arsenite Inhibits ER Ca2+-ATPase

13

Table 1. Liver Microsomal Ca2+ -ATPase Activities of Rats Exposed to Sodium
Arsenite (2.4 mg/kg body weight) Alone and After Pretreatment with Vitamin C.
ATPase Activity was Determined as Described in Materials and Methods

Group

Number of
experiments

Microsomal
protein
(Ug/ml)

Microsomal Ca2+ -ATPase
activity
(Umole Pi/mg protein/hr)

NaAsO2
NaAsO2 + Vit. C
Control

6
6
6

7.50 ±2.80
7.90 ±2.44
7.16 ±2.94

21.30±1.29*
44.10 ±2.25
45.21 ±1.75

Values are means ± SD.
*
Significantly different from control at p<0.05.

ER Ca2 +-ATPase Assay

The Ca2 + -dependent ATPase activity was assayed in a final reaction mixture of
1 ml containing 100 mM KCl, 20 mM Tris, pH 7.2, 2 mM NaN3, 1 mM MgCl2, with
or without 2 mM CaCl2. When CaCl2 was not present, 4 mM EGTA was used
instead. The reaction was initiated by adding 5 mM ATP and terminated after 30
minutes of incubation at 37°C, with the addition of 50 Ul of 50% trichloroacetic acid.
Liberated inorganic phosphate (Pi) was measured by the conventional method of
[11]. The difference in activity in the presence and absence of 2 mM CaCl2 was used
to calculate the Ca2+-ATPase activity. The procedure was repeated using different
concentrations or CaCl2. One unit of enzyme was taken to be the amount of enzyme
that released 1 nmole of Pi per minute.
RESULTS
Table 1 shows the liver microsomal Ca2+-ATPase activities of rats after exposure to sodium arsenite (2.4 mg/kg body weight) alone and in combination with
vitamin C. There was a marked decrease in the microsomal Ca2+-ATPase activities
of rats given NaAsO2 alone to about 50% in comparison with that of the control
rats. Similarly, the activity of the enzyme in rats pretreated with vitamin C and
later administered NaAsO2 was found to be twice that of rats given NaAsO2 alone.
However, no appreciable difference was observed between the microsomal Ca2+ATPase activities of rats given the combined regimen and that of the control group.
Figure 1 presents the Ca2+-dependence profiles of liver microsomal Ca2+-ATPase
of rats treated with sodium arsenite alone and after vitamin C pretreatment. The
result showed that the affinity of liver ER Ca2+-ATPase for Ca2+ was drastically
reduced after in vivo administration of sodium arsenite. Treatment with vitamin C
prior to the administration of the carcinogen significantly lowered the extent of
inhibition of the enzyme.
DISCUSSION
The endoplasmic reticulum Ca2+-ATPase is involved in the fine regulation of
calcium ion level in the cell [12]. Investigations have revealed that tumor promoters
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Fig. 1. Activity of liver microsomal Ca2+-ATPase of rats administered sodium arsenite (SA)
alone and in combination with vitamin C, at different Ca2+ concentrations. Ca2 + -ATPase
activity was determined as described in Materials and Methods.

depress the ER Ca2 + -ATPase [5–7, 13]. In this experiment sodium arsenite was
found to significantly decrease the specific activity of the hepatic endoplasmic reticulum Ca2 + -ATPase in rats (Table 1). This observation supports previous findings [57, 13]. The specific activity of the enzyme in sodium arsenite—rats previously treated
with vitamin C did not show significant difference when compared with control rats.
When compared with that of rats exposed to NaAsO2 alone a significant decrease
to about 50% was observed.
The drastic depression of the activity of the ER Ca2+ pump will result in an
increase in cytosolic free Ca2 +, a condition which favors positive response of cells
to mitogen including growth factors and tumor promoters. For instance, [14]
reported that administration of triiodo-L-thyronine to rats lowered the activity of
the liver microsomal Ca2+-dependent ATPase and altered Ca2+ sequestration in the
rat liver microsomes.
The mechanism by which this inhibition occurs is not known. It may be due to
non-competitive inhibition of the enzyme by NaAsO2. Sodium arsenite may bind
covalently to groups on the enzyme molecule. On the other hand, the inhibition
could be brought about by indirect interaction microsomal membrane. If this is the
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case, the topology of the Ca2 + -ATPase, an enzyme known to be sensitive to its
immediate lipid environment will be adversely affected. This may result in drastic
reduction in the activity of the enzymes. This suggestion is further supported by the
fact that many carcinogens act by generating free radicals. Generation of free radicals will ultimately result in membrane damage via peroxidation of membrane phospholipids. More investigations are however required to unravel and establish the
mechanism of action of the compound.
Vitamin C has been shown to possess antimutagenic property against a number
of carcinogens [9]. However, ascorbic acid seems not to be effective when toxicological manifestations are already established. This is in conformity with the role of
vitamin C as an extracellular free radical scavenger molecule [15].
In conclusion, sodium arsenite at one tenth of its median lethal dose was found
to depress rat liver endoplasmic reticulum (ER) Ca2 + -ATPase by 50% in comparison
with control. This depression however was significantly reversed by vitamin C
pretreatment.
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